SOURCE: Crystal Research Associates, LLC

Crystal Research Associates, LLC

November 04, 2013 10:47 ET

Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Pressure BioSciences, Inc.

NEW YORK, NY--(Marketwired - Nov 4, 2013) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO) on Pressure BioSciences, Inc. (OTCQB: PBIO). The full 76-page report is available on Crystal Research Associates' website at

Pressure BioSciences, Inc. ("Pressure BioSciences" or "the Company") develops and commercializes proprietary laboratory instruments and consumable products. Its product portfolio is based on its patented pressure cycling technology (PCT) platform, which is able to apply and release high levels of hydrostatic pressure in a safe and controlled manner. The Company has installed roughly 235 Barocycler instruments in approximately 150 academic, government, biotechnology, and pharmaceutical laboratories, including many of the top laboratories in the U.S. To date, there are over 100 publications from leading scientists on the multiple advantages of the PCT platform.

While this technology has applications across many industries, Pressure BioSciences is initially using PCT to develop products that improve sample preparation -- the vitally important process of preparing a sample for analysis. In life science research, sample preparation is integral to tens of thousands of laboratories worldwide yet it is often a significant bottleneck to discovery and progress.

Pressure BioSciences' line of Barocycler® products enables scientists to harness the power of PCT in the lab. Biological samples (e.g., cells and tissues from humans, animals, plants, and microbes) are placed in single-use processing tubes inside a Barocycler instrument and exposed to programmable cycles of low-to-intense pressure -- up to 58,000 psi. This act of "cycling" pressure can accelerate and control physical and chemical processes, including the breakup of cellular structures and release of biomarkers from a sample for subsequent testing and analysis. Pressure BioSciences' portfolio also includes Shredder instruments (for rapidly shredding or grinding samples), sample preparation kits and reagents, and related consumable products (e.g., tubes to hold the samples during the PCT process).

Be the first to hear about Crystal Research's new report releases and upcoming media coverage. Follow us on Twitter at and LinkedIn at or visit for more coverage.

About Crystal Research Associates, LLC

For the past decade, Crystal Research Associates, LLC ( has successfully articulated the exceptional stories of small- and mid-cap companies to the Wall Street investor community. Our methods are well-established and diverse, from compiling and disseminating objective, factual information for both institutional and retail investor audiences to capitalizing on our expansive line of targeted distribution channels, which include industry-leading financial data and information providers. Our distribution efforts are accompanied by the use of prominent social media channels and by strategic and targeted appearances on national news programs and print media.

Crystal Research Associates is led by Wall Street veterans, Jeffrey Kraws and Karen Goldfarb. Together, Kraws and Goldfarb have built a unique business model, capitalizing on decades of experience as an award-winning sell-side analyst team to produce institutional-quality industry and market research in a manner that is easily understood by investors and consumers. Our firm's approach has been proven successful over the years as our products are published and available on Bloomberg, Thomson Reuters/First Call, Capital IQ, FactSet, Yahoo! Finance, and scores of other popular forums.

Forward-Looking Safe Harbor Statement

Statements in this news release regarding future financial and operating results, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including limited operating history, need for future capital, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic news and reports. Crystal Research Associates has been compensated by the Company in cash of thirty-nine thousand, five hundred U.S. dollars and one hundred thousand warrants for its services in creating this report and for updates.

These statements, and other forward-looking statements, are not guarantees of future performance and involve risks and uncertainties. Crystal Research Associates assumes no obligation to update any of the forward-looking statements in this release.

Contact Information

  • Contact:

    Jeffrey J. Kraws/Karen B. Goldfarb
    Crystal Research Associates, LLC
    P: (609) 306-2274
    F: (609) 395-9339